Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 52.51

+2.7%

Nov 14 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Ian@SI who wrote (23241)	3/18/2007 5:50:47 PM
From: Mike McFarland	of 52153

Well these are "portfolios" versus real mutual funds. Here is an article with a few funds and YTD performance as of March 2nd: 1. Jennison Health Sciences A (PHLAX) +5.7% 2. Fidelity Select Medical Delivery (FSHCX) +4.7% 3. Live Oak Health sciences (LOGSX) +4.0% 4. Janus Global Life Sciences (JAGLX) +3.9% 5. BlackRock Healthcare A (MDHCX) +3.8% 247wallst.com When I first started dabbling in biotech I owned FBIOX. Here on SI in August 1997 I wrote I will give you my pick of an industry however--biotech. Very hazardous to choose individual companies though and since you asked us not to hype individual stocks, I wont--see my profile for individual picks. Ha! Over time, I learned not to list my favorite stocks on my profile. It is probably taken me ten years to appreciate the negative effect a set of pet stocks (Peter once used that term) can have on your portfolio.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next